Glenmark to pay USD 7 mn to settle lawsuits with three entities in U.S.
Glenmark Pharmaceuticals settles U.S. lawsuits for $7 million related to generic drugs, denying all allegations.
Key milestones in Vivek Ramaswamy’s academic journey: From being a Valedictorian to a member of Harvard Political Union
Vivek Ramaswamy, an Indian-American entrepreneur, has launched his campaign for Ohio governor with endorsements from Donald Trump and Elon Musk. Ramas ...
The Motley Fool on MSN17d
3 Magnificent S&P 500 Dividend Stocks Down 36% to 64% to Buy and Hold Forever
It acquired Keytruda, for instance, when the company acquired Schering-Plough back in 2009. In this same vein, in November it secured the rights to a promising immunotherapy being developed by China's ...
Washingtonian28d
“Wonder Woman” Lynda Carter on Transitioning From Hollywood to Washington
But DC was a very different world than Hollywood. Here, the longtime Potomac resident looks back. “I met Robert at a dinner in Memphis for Schering-Plough, which owned Maybelline. I was there for ...
Indiatimes15d
Vivek Ramaswamy on track to become third US governor of Indian-origin
His mother Geeta Ramaswamy is a graduate of Mysore Medical College and worked as a geriatric psychiatrist for Merck and Schering-Plough, while his father Ganapathy Ramaswamy, a graduate of the ...
The Motley Fool17d
3 Magnificent S&P 500 Dividend Stocks Down 36% to 64% to Buy and Hold Forever
It acquired Keytruda, for instance, when the company acquired Schering-Plough back in 2009. In this same vein, in November it secured the rights to a promising immunotherapy being developed by ...
Medscape7d
Baseline Factors Associated With Congestive Heart Failure in Patients Receiving Etoricoxib or Diclofenac: Multivariate Analysis of the MEDAL Program
Aims: Non-steroidal anti-inflammatory drugs have been associated with increased risk of congestive heart failure (CHF). We aimed to assess the impact of treatment with etoricoxib or diclofenac on ...
Hosted on MSN17d
Glenmark to pay $7 million to settle lawsuits with three entities in US
Merck Sharp & Dohme Corp (now known as Merck Sharp & Dohme LLC), and Schering-Plough Corp. Glenmark and Merck disputed these claims and defended these matters vigorously. Glenmark shares were ...